14th Annual Biosimilars Summit
January 22 - 23, 2019 - Alexandria VA US

As more biosimilar products continue to be added to the FDA pipeline, it is critical that pharmaceutical companies develop strategies to navigate evolving regulations, educate stakeholders in cross functional areas and execute long-term decisions to prepare for success. At CBI’s 14th Biosimilars Summit, you’ll gain insights from industry experts on the tools and strategies needed to prepare for the current changes impacting all elements of the healthcare industry.

More Information